Patents-Review.com
ClassID:

169287 ⎘

G01N33/5767 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Recent Application in this class:
#1
20260078172
2026-03-19

HCV ANTIGENS AND ANTIBODIES

 #2
20250215048
2025-07-03

ASSEMBLED GLYCOPROTEINS

 #3
20230340030
2023-10-26

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

 #4
20230331784
2023-10-19

HCV Recombinant Antigen and Application

 #5
20230331783
2023-10-19

HCV Recombinant Antigen and Mutant thereof

 #6
20230184758
2023-06-15

AUTOIMMUNE HEPATITIS BIOMARKERS

 #7
20220317120
2022-10-06

USE OF PROTEINS PD-1 AND CD38 AS MARKERS OF AN ACTIVE AUTO-IMMUNE PATHOLOGY

 #8
20220283161
2022-09-08

METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV)

 #9
20220252614
2022-08-11

Hepatitis C Virus Detection Kit

 #10
20220119502
2022-04-21

KAWASAKI DISEASE ANTIBODIES IDENTIFY HEPACIVIRUS PEPTIDES

 #11
20220034889
2022-02-03

SAMPLE PRETREATMENT METHOD FOR VIRUS DETECTION

 #12
20220033479
2022-02-03

ANTI-HEPATITIS C VIRUS ANTIBODIES

 #13
20210324049
2021-10-21

ANTIBODIES HAVING SPECIFICITY FOR THE ORF2I PROTEIN OF HEPATITIS E VIRUS AND USES THEREOF FOR DIAGNOSTIC PURPOSES

 #14
20210269510
2021-09-02

ANTIBODIES HAVING SPECIFICITY FOR THE ORF2I PROTEIN OF HEPATITIS E VIRUS AND USES THEREOF FOR DIAGNOSTIC PURPOSES

 #15
20210231665
2021-07-29

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

 #16
20210179669
2021-06-17

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

 #17
20210041442
2021-02-11

Subject anti-HCV antibody detection assays employing NS3 capture peptides

 #18
20200264178
2020-08-20

Method and means for diagnosing autoimmune hepatitis using autoantibody markers

 #19
20200217846
2020-07-09

Target marker GP73 for detecting steatohepatitis and detection application method

 #20
20200148726
2020-05-14

Multi-epitope fusion protein of an HCV antigen and uses thereof

 #21
20200141937
2020-05-07

DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES

 #22
20200064345
2020-02-27

METHODS FOR SCREENING INFECTIONS

 #23
20200033344
2020-01-30

DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES

 #24
20190352342
2019-11-21

Hepatitis E virus ORF2 capsid polypeptides and uses thereof

 #25
20190346432
2019-11-14

Immunoassay using at least two pegylated analyte-specific binding agents

 #26
20190284230
2019-09-19

Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)

 #27
20190276904
2019-09-12

METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS

 #28
20190271700
2019-09-05

HCV NS4a/modified NS3 polypeptides and uses thereof

 #29
20190185525
2019-06-20

Epitope

 #30
20190170753
2019-06-06

HCV core and minicore binding molecules

 #31
20190086413
2019-03-21

Pretreatment method for rapid detection of HCV core antigen

 #32
20190086412
2019-03-21

Method for serological detection of viral antigens

 #33
20190064169
2019-02-28

Subject anti-HCV antibody detection assays employing NS3 capture peptides

 #34
20180292408
2018-10-11

CAMELID SINGLE-DOMAIN HCV ANTIBODIES AND METHODS OF USE

 #35
20180156799
2018-06-07

Reagents for HCV antigen-antibody combination assays

 #36
20180136211
2018-05-17

METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS

 #37
20180023058
2018-01-25

Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof

 #38
20180011096
2018-01-11

HCV NS4A/modified NS3 polypeptides and uses thereof

 #39
20180002763
2018-01-04

Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients

 #40
20170335345
2017-11-23

Pharmaceutical composition for treatment and/or prevention of hepatitis C

 #41
20170327803
2017-11-16

HCV NS3 RECOMBINANT ANTIGENS AND MUTANTS THEREOF FOR IMPROVED ANTIBODY DETECTION

 #42
20170283484
2017-10-05

Anti-hepatitis C antibodies and antigen binding fragments thereof

 #43
20170242010
2017-08-24

Combo-Hepatitis Antigen Assays and Kits for Detection of Active Hepatitis Virus Infections

 #44
20170052184
2017-02-23

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

 #45
20170052183
2017-02-23

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

 #46
20170043011
2017-02-16

Synthetic hepatitis C polypeptide and methods of making and using same

 #47
20170003290
2017-01-05

HCV antigen-antibody combination assay and methods and compositions for use therein

 #48
20160377620
2016-12-29

COMBINATION HEPATITIS C VIRUS ANTIGEN AND ANTIBODY DETECTION METHOD

 #49
20160291020
2016-10-06

HCV core lipid binding domain monoclonal antibodies

 #50
20160251734
2016-09-01

Use of Let-7g to down regulate NS5B gene, core protein and viral load of hepatitis C virus

 #51
20160131653
2016-05-12

Subject anti-HCV antibody detection assays employing NS3 capture peptides

 #52
20160123983
2016-05-05

HCV ANTIGEN-ANTIBODY COMBINATION ASSAY AND METHODS AND COMPOSITIONS FOR USE THEREIN

 #53
20160109451
2016-04-21

Compositions and methods for simultaneous detection of HCV antigen/antibody

 #54
20160109447
2016-04-21

Reagents for HCV antigen-antibody combination assays

 #55
20160077109
2016-03-17

CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF HUMAN SERUM PROTEIN BIOMARKERS

 #56
20150291684
2015-10-15

Hepatitis C virus neutralizing antibodies and methods

 #57
20150210984
2015-07-30

METHOD FOR REPLICATING HCV IN VITRO

 #58
20150204876
2015-07-23

Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients

 #59
20150177242
2015-06-25

Combination hepatitis C virus antigen and antibody detection method

 #60
20150118242
2015-04-30

Hepatitis C virus neutralizing antibody

 #61
20150105293
2015-04-16

CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS

 #62
20140349314
2014-11-27

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE

 #63
20140286995
2014-09-25

Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a

 #64
20140272933
2014-09-18

HCV antigen-antibody combination assay and methods and compositions for use therein

 #65
20140272932
2014-09-18

HCV NS3 recombinant antigens and mutants thereof for improved antibody detection

 #66
20140272931
2014-09-18

HCV core lipid binding domain monoclonal antibodies

 #67
20140051079
2014-02-20

METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT AGAINST HEPATITIS C

 #68
20130323282
2013-12-05

Compositions and methods

 #69
20130316332
2013-11-28

Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatment

 #70
20130116148
2013-05-09

LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION

 #71
20130071421
2013-03-21

TURKEY VIRAL HEPATITIS VIRUS AND USES THEREOF

 #72
20130059890
2013-03-07

ANTIVIRAL AGENTS

 #73
20130059749
2013-03-07

METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY

 #74
20130052634
2013-02-28

HCV genotype 4 replicons

 #75
20130052206
2013-02-28

Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients

 #76
20130012429
2013-01-10

ANTI-VIRAL THERAPY

 #77
20120276521
2012-11-01

Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes

 #78
20120202295
2012-08-09

Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies

 #79
20120183497
2012-07-19

Method of Determining Response to Treatment with Immunomodulatory Composition

 #80
20120171158
2012-07-05

METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS

 #81
20120100574
2012-04-26

Flavivirus-based system for production of hepatitis C virus (HCV)

 #82
20120093849
2012-04-19

Agents for treatment of HCV and methods of use

 #83
20120088904
2012-04-12

ANALYSIS OF HCV GENOTYPES

 #84
20120083458
2012-04-05

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE

 #85
20120082677
2012-04-05

COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV

 #86
20120046188
2012-02-23

Solid Support for HCV Detection

 #87
20120035347
2012-02-09

INTERFERON-ALFA SENSITIVITY BIOMARKERS

 #88
20120009196
2012-01-12

MONOCLONAL ANTIBODIES AGAINST HEPATITIS C VIRUS CORE PROTEIN

 #89
20120009148
2012-01-12

METHODS OF PREDICTING RESPONSIVENESS TO INTERFERON TREATMENT AND TREATING HEPATITIS C INFECTION

 #90
20110312513
2011-12-22

BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT

 #91
20110281747
2011-11-17

BIOMARKERS FOR PREDICTING RAPID RESPONSE TO HCV TREATMENT

 #92
20110263436
2011-10-27

Recombinant antibodies against hepatitis C virus and methods of obtaining and using same

 #93
20110262892
2011-10-27

METHODS FOR DETECTION OR MEASUREMENT OF VIRUSES

 #94
20110251085
2011-10-13

IN VITRO METHOD TO DETERMINE WHETHER A DRUG CANDIDATE ACTIVE AGAINST A TARGET PROTEIN IS ACTIVE AGAINST A VARIANT OF SAID PROTEIN

 #95
20110244549
2011-10-06

Hepatitis C virus variants

 #96
20110229488
2011-09-22

Progastrin and liver pathologies

 #97
20110183364
2011-07-28

ANALYTICAL METHOD FOR THE DETECTION OF LATENT HEPATITIS C, USE THEREOF AND CORRESPONDING DIAGNOSIS KIT

 #98
20110166203
2011-07-07

Anti-hepatitis C virus composition

 #99
20110158908
2011-06-30

CYCLOSPORIN A-BINDING PROTEIN

 #100
20110135605
2011-06-09

METHODS AND PRODUCTS RELATED TO TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION

 #101
20110129815
2011-06-02

METHOD FOR PRETREATING SAMPLE FOR DETECTION HCV CORE PROTEIN, REAGENT KIT FOR DETECTION OF HCV CORE PROTEIN, METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF HEPATITIS C VIRUS IN SAMPLE, AND METHOD FOR IMMUNOASSAY OF HCV

 #102
20110091994
2011-04-21

Methods for Screening Compounds for Treating and/or Preventing an Hepatitis C Virus Infection

 #103
20100316608
2010-12-16

Method of Determining A Response To Treatment With Immunomodulatory Composition

 #104
20100298418
2010-11-25

Assay for measuring plasma FGL-2 and methods and uses thereof

 #105
20100297607
2010-11-25

Reagents For HCV Antigen-Antibody Combination Assays

 #106
20100297605
2010-11-25

Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C

 #107
20100291602
2010-11-18

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers

 #108
20100291130
2010-11-18

CLONED GENOME OF INFECTIOUS HEPATITIS C VIRUS STRAIN HC-TN AND USES THEREOF

 #109
20100247522
2010-09-30

Neutralization of HCV

 #110
20100226885
2010-09-09

METHOD OF TREATING HEPATITIS C PATIENTS

 #111
20100203501
2010-08-12

Assay to detect HCV receptor binding

 #112
20100203498
2010-08-12

METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS

 #113
20100183555
2010-07-22

METHODS AND KITS FOR DETERMINING DRUG SENSITIVITY IN PATIENTS INFECTED WITH HCV

 #114
20100173298
2010-07-08

HCV GENE

 #115
20100167302
2010-07-01

METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY

 #116
20100159467
2010-06-24

METHOD FOR REPLICATING THE HEPATITIS C VIRUS

 #117
20100152110
2010-06-17

ALTERNATE READING FRAME POLYPEPTIDES DERIVED FROM HEPATITIS C AND METHODS OF THEIR USE

 #118
20100151490
2010-06-17

Antigenic Protein Conjugates and Process for Preparing Same

 #119
20100137562
2010-06-03

MAVS IN THE PREVENTION AND TREATMENT OF VIRAL DISEASE

 #120
20100136010
2010-06-03

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

 #121
20100093018
2010-04-15

CELLS EXPRESSING CHIMERIC PROTEINS AND ASSAYS USING SUCH CELLS

 #122
20100074890
2010-03-25

Methods for identifying HCV protease inhibitors

 #123
20100062419
2010-03-11

Infectious, Chimeric Hepatitis C Virus, Methods of Producing the Same and Methods of Use Thereof

 #124
20100047896
2010-02-25

Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle

 #125
20100041018
2010-02-18

METHOD TO DETECT VIRUS RELATED IMMUNOLOGICAL MARKERS FOR THE DIAGNOSIS OF HEPATITIS C VIRUS INFECTION

 #126
20100040577
2010-02-18

Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections

 #127
20100028922
2010-02-04

IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO

 #128
20090252755
2009-10-08

Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

 #129
20090252745
2009-10-08

Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis

 #130
20090239794
2009-09-24

HCV F PROTEIN AND USES THEREOF

 #131
20090233266
2009-09-17

STRUCTURE OF THE HEPATITIS C VIRUS NS2 PROTEIN

 #132
20090136515
2009-05-28

Methods of diagnosing, preventing and treating infection with Hepatitis C virus

 #133
20090104188
2009-04-23

ANTI-HEPATITIS C VIRUS ANTIBODY AND USES THEREOF

 #134
20090098528
2009-04-16

Method for determining early HCV seroconversion

 #135
20090081636
2009-03-26

Pharmaceutical compositions for and methods of inhibiting HCV replication

 #136
20080299544
2008-12-04

HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof

 #137
20080286752
2008-11-20

Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV

 #138
20080241855
2008-10-02

Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism

 #139
20080241162
2008-10-02

Human monoclonal antibody Fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity

 #140
20080227111
2008-09-18

REAGENT KIT AND METHOD FOR MEASURING HCV ANTIBODY

 #141
20080220448
2008-09-11

ANTIGENIC PROTEIN CONJUGATES AND PROCESS FOR PREPARING SAME

 #142
20080220410
2008-09-11

Nucleotide sequences coding for the non-structural proteins of the hepatitis C virus

 #143
20080220019
2008-09-11

Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle

 #144
20080207760
2008-08-28

Pharmaceutical Compositions For and Methods of Inhibiting Hcv

 #145
20080182895
2008-07-31

IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO HCV-796, AND METHODS RELATED THERETO

 #146
20080176219
2008-07-24

Assay to detect HCV receptor binding

 #147
20080153089
2008-06-26

Blocked Enzyme-Probe Complex

 #148
20080131912
2008-06-05

Recombinant antibodies against hepatitis C virus and methods of obtaining and using same

 #149
20080125367
2008-05-29

Agents for treatment of HCV and methods of use

 #150
20080125362
2008-05-29

Method of screening compound preventing cells from infection with Hepatitis C virus (HCV)

 #151
20080119388
2008-05-22

Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy

 #152
20080113399
2008-05-15

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

 #153
20080113339
2008-05-15

Combination hepatitis C virus antigen and antibody detection method

 #154
20080108093
2008-05-08

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

 #155
20080085526
2008-04-10

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers

 #156
20080063643
2008-03-13

Peptide Derived From Hepatitis C Virus

 #157
20080044807
2008-02-21

Method of detecting hepatitis C virus

 #158
20080003614
2008-01-03

MAVS in the prevention and treatment of viral diseases

 #159
20070298410
2007-12-27

Assay to detect HCV receptor binding

 #160
20070231262
2007-10-04

Hepatitis C virus variants

 #161
20070212717
2007-09-13

Method for Inhibiting Hepatitis C Virus Replication

 #162
20070166702
2007-07-19

Methods for predicting the efficacy or outcome of hcv therapy

 #163
20070122855
2007-05-31

METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA

 #164
20070092898
2007-04-26

Detection of multiple anti-viral antibodies

 #165
20070032635
2007-02-08

Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes

 #166
20060292556
2006-12-28

Method of detecting antibodies to HCV

 #167
20060292151
2006-12-28

L-SIGN polymorphisms and methods involving use of same

 #168
20060263854
2006-11-23

Immunodiagnostic assays using reducing agents

 #169
20060257850
2006-11-16

Methods of treatment and diagnosis of patients with hepatitis c infection

 #170
20060246035
2006-11-02

Methods and products related to treatment and prevention of hepatitis C virus infection

 #171
20060234214
2006-10-19

Methods of detecting hepatitis C virus

 #172
20060210969
2006-09-21

Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof

 #173
20060199174
2006-09-07

Methods and compositions for identifying anti-HCV agents

 #174
20060198855
2006-09-07

Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection

 #175
20060166193
2006-07-27

Hepatitis C virus E2 binding protein

 #176
20060153833
2006-07-13

Anti hepatitis C virus antibody and uses thereof

 #177
20060121448
2006-06-08

Method for inducing complete hepatitis c virus (hcv) replication in vitro

 #178
20060104980
2006-05-18

Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes

 #179
20060084057
2006-04-20

Methods of diagnosing liver fibrosis

 #180
20060051745
2006-03-09

HCV non-structural protein mutants and uses thereof

 #181
20060035212
2006-02-16

Molecules inhibiting hepatitis c virus protein synthesis and method for screening same

 #182
20060019271
2006-01-26

Submergence-induced protein-like factors

 #183
20060009632
2006-01-12

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

 #184
20060003962
2006-01-05

Methods and products related to treatment and prevention of hepatitis C virus infection

 #185
20050282179
2005-12-22

Biomarkers for interferon-alpha response in hepatitis C virus infected patients

 #186
20050260568
2005-11-24

Hepatitis C virus assays

 #187
20050260221
2005-11-24

Hepatitis C virus constructs characterized by high efficiency replication

 #188
20050221297
2005-10-06

Diagnostic reagent for hepatitis C virus infection

 #189
20050202418
2005-09-15

HCV peptide compositions

 #190
20050202036
2005-09-15

Alternate reading frame polypeptides drived from hepatitis C and methods of their use

 #191
20050181356
2005-08-18

Hepatitis C virus assay systems

 #192
20050095584
2005-05-05

Method for determining early HCV seroconversion

 #193
20050089839
2005-04-28

Assay

 #194
20050084845
2005-04-21

Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity

 #195
20050069865
2005-03-31

Synthetic hcv envelope proteins and their use for vaccination

 #196
20050019751
2005-01-27

Screening for hepatitis c virus entry inhibitors

 #197
20050009877
2005-01-13

Methods of identifying HCV NS5B polymerase inhibitors and their uses

 #198
20050009011
2005-01-13

Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes